21. National women's health action at the F.D.A. Sept. 20, 1994 Publication: [United States : s.n.], 1994 Subject(s): Women's HealthDrug IndustryDrugs, InvestigationalDrug ApprovalUnited States. Food and Drug Administration.
22. Benefit-risk assessment for new drug and biological products: guidance for industry Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023 Subject(s): Biological ProductsDrug ApprovalDrug IndustryDrugs, InvestigationalGovernment RegulationPharmaceutical PreparationsRisk AssessmentUnited States
23. Real-time oncology review (RTOR): guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, November 2023 Subject(s): Biological ProductsDrug ApprovalDrug IndustryDrugs, InvestigationalGovernment RegulationNeoplasms -- drug therapyUnited States